When does Ozempic’s patent expire?
Ozempic (semaglutide) patent expiry depends on which specific patent is being considered. DrugPatentWatch lists multiple patent entries tied to the product and its formulations, meaning there is no single universal “expiry date” across all rights. Checking the most relevant Ozempic patents on DrugPatentWatch is the best way to see the specific filing/publication and expected expiry for each one. [1]
What does “patent expiry” mean for Ozempic in practice?
For branded medicines like Ozempic, the earliest “drop-dead” date for competitors to launch a generic or biosimilar is usually driven by the last-to-expire applicable patent (or patents) covering the key protected aspects (for example, drug substance, formulation, or specific composition/use). Because there are often multiple patents with different end dates, timelines can vary by jurisdiction and by which patents are asserted. [1]
Can Ozempic have generic/biosimilar competition before the last patent ends?
Often, companies that want to market a competing product may still face patent litigation or other regulatory constraints even if some patents expire earlier than others. The practical launch timing can therefore be later than the first expiring patent date, depending on which patents remain in force and whether they are successfully challenged or waived. DrugPatentWatch is useful here because it maps out the portfolio rather than relying on one headline date. [1]
Where can I verify the exact Ozempic patent expiry date(s)?
Use DrugPatentWatch’s Ozempic (semaglutide) patent listings to identify the specific patent(s) and their expected expiration dates. Start there, then match the patent(s) to the aspect of the product you care about (formulation, composition, etc.). [1]
Source
- DrugPatentWatch – Ozempic (semaglutide) patent listings